Von Willebrand factor inhibition improves endothelial function in patients with stable angina

Journal of Cardiovascular Translational Research

Volumn 6, Issue 3, 2013, Pages 364-370

  Muller, Olivier ^a   Bartunek, Jozef ^a   Hamilos, Michalis ^a   Berza, Catalina Trana ^a   Mangiacapra, Fabio ^a   Ntalianis, Argyrios ^a   Vercruysse, Kristof ^b   Duby, Christian ^b   Wijns, William ^a   De Bruyne, Bernard ^a   Heyndrickx, Guy R ^a   Vanderheyden, Marc ^a   Holz, Josefin Beate ^b   Barbato, Emanuele ^a  

^a CARDIOVASCULAR CENTER   (Belgium)

^b ABLYNX NV   (Belgium)

Author keywords

Coronary artery disease; Endothelial function; Nano antibody; PCI; von Willebrand factor

Indexed keywords

ALX 0081; PLACEBO; PROTEIN ANTIBODY; PURINERGIC P2Y12 RECEPTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; FRACTIONAL FLOW RESERVE; GLOMERULUS FILTRATION RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STABLE ANGINA PECTORIS; SYSTOLIC BLOOD PRESSURE; TONOMETRY; VASCULAR ENDOTHELIUM;

AGED; ANGINA, STABLE; BELGIUM; BIOLOGICAL MARKERS; CELL-DERIVED MICROPARTICLES; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HEMODYNAMICS; HUMANS; MALE; MANOMETRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; SINGLE-DOMAIN ANTIBODIES; TIME FACTORS; TREATMENT OUTCOME; VON WILLEBRAND FACTOR;

ANGINA;

EID: 84877784741     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9422-3     Document Type: Article

References (37)

1. Reriani, M. K., Lerman, L. O., & Lerman, A. (2010). Endothelial function as a functional expression of cardiovascular risk factors. Biomarkers in Medicine, 4(3), 351-360.
2. Lembo, G., Morisco, C., Lanni, F., Barbato, E., Vecchione, C., Fratta, L., & Trimarco, B. (1998). Systemic hypertension and coronary artery disease: the link. The American Journal of Cardiology, 82, 2H-7H.
3. Barbato, E., Bartunek, J., Wyffels, E., Wijns, W., Heyndrickx, G. R., & De Bruyne, B. (2003). Effects of intravenous dobutamine on coronary vasomotion in humans. Journal of the American College of Cardiology, 42, 1596-1601.
4. Barbato, E., Piscione, F., Bartunek, J., Galasso, G., Cirillo, P. L., De Luca, G., Iaccarino, G., De Bruyne, B., Chiariello, M., & Wijns, W. (2005). Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation, 111(3), 288-294.
5. Bonetti, P. O., Lerman, L. O., & Lerman, A. (2003). Endothelial dysfunction: a marker of atherosclerotic risk. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(2), 168-175.
6. Brevetti, G., Piscione, F., Cirillo, P., Galasso, G., Schiano, V., Barbato, E., Scopacasa, F., & Chiariello, M. (2008). In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction. Atherosclerosis, 201(2), 440-446.
7. Treasure, C. B., Klein, J. L., Weintraub, W. S., Talley, J. D., Stillabower, M. E., Kosinski, A. S., Zhang, J., Boccuzzi, S. J., Cedarholm, J. C., & Alexander, R. W. (1995). Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. The New England Journal of Medicine, 332(8), 481-487.
8. Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Jr., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., Nordestgaard, B. G., Shepherd, J., Willerson, J. T., & Glynn, R. J. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England Journal of Medicine, 359(21), 2195-2207.
9. Hambrecht, R., Wolf, A., Gielen, S., Linke, A., Hofer, J., Erbs, S., Schoene, N., & Schuler, G. (2000). Effect of exercise on coronary endothelial function in patients with coronary artery disease. The New England Journal of Medicine, 342(7), 454-460.
10. Hamilos, M., Sarma, J., Ostojic, M., Cuisset, T., Sarno, G., Melikian, N., Ntalianis, A., Muller, O., Barbato, E., Beleslin, B., Sagic, D., De Bruyne, B., Bartunek, J., & Wijns, W. (2008). Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circulation Cardiovascular Interventions, 1(3), 193-200.
11. Vischer, U. M. (2006). von Willebrand factor, endothelial dysfunction, and cardiovascular disease. Journal of Thrombosis and Haemostasis, 4(6), 1186-1193.
12. Muller, O., Hamilos, M., Bartunek, J., Ulrichts, H., Mangiacapra, F., Holz, JB., et al. Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention. American Journal of Cardiology, 105(3), 333-338
13. Bickel, C., Rupprecht, H. J., Blankenberg, S., Espinola-Klein, C., Rippin, G., Hafner, G., Lotz, J., Prellwitz, W., & Meyer, J. (2002). Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion. International Journal of Cardiology, 82(1), 25-31.
14. Companion paper from Bartunek, J., & Holtz J. (2013). Novel antiplatelet agents: ALX-0081, a nanobody directed toward von Willebrand factor. Journal Cardiovascular Translational Research
15. Cuisset, T., Hamilos, M., Melikian, N., Wyffels, E., Sarma, J., Sarno, G., Barbato, E., Bartunek, J., Wijns, W., & De Bruyne, B. (2008). Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation. Journal of the American College of Cardiology, 51(11), 1060-1065.
16. Hamburg, N. M., Keyes, M. J., Larson, M. G., Vasan, R. S., Schnabel, R., Pryde, M. M., Mitchell, G. F., Sheffy, J., Vita, J. A., & Benjamin, E. J. (2008). Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham heart study. Circulation, 117(19), 2467-2474.
17. Cuisset, T., Hamilos, M., Sarma, J., Sarno, G., Wyffels, E., Vanderheyden, M., Barbato, E., Bartunek, J., De Bruyne, B., & Wijns, W. (2008). Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. The American Journal of Cardiology, 101(12), 1700-1703.
18. Mangiacapra, F., De Bruyne, B., Muller, O., Trana, C., Ntalianis, A., Bartunek, J., Heyndrickx, G., Di Sciascio, G., Wijns, W., & Barbato, E. (2010). High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention. Journal American College of Cardiology Cardiovasc Intervention, 3(1), 35-40.
19. Hamilos, M., Muller, O., Ntalianis, A., Trana, C., Bartunek, J., Sarno, G., Mangiacapra, F., Dierickx, K., Meeus, P., Cuisset, T., De Bruyne, B., Wijns, W., & Barbato, E. (2011). Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel. Journal of Thrombosis and Thrombolysis, 32(1), 64-71.
20. Ulrichts, H., Silence, K., Schoolmeester, A., de Jaegere, P., Rossenu, S., Roodt, J., Priem, S., Lauwereys, M., Casteels, P., Van Bockstaele, F., Verschueren, K., Stanssens, P., Baumeister, J., & Holz, J. B. (2011). Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs. Blood, 118(3), 757-765.
21. Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007). Endothelial function and dysfunction: testing and clinical relevance. Circulation, 115(10), 1285-1295.
22. Hansson, G. K. (2005). Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine, 352(16), 1685-1695.
23. Jilma, B., Pernerstorfer, T., Dirnberger, E., Stohlawetz, P., Schmetterer, L., Singer, E. A., Grasseli, U., Eichler, H. G., & Kapiotis, S. (1998). Effects of histamine and nitric oxide synthase inhibition on plasma levels of von Willebrand factor antigen. The Journal of Laboratory and Clinical Medicine, 131(2), 151-156.
24. Pernerstorfer, T., Stohlawetz, P., Kapiotis, S., Eichler, H. G., & Jilma, B. (2000). Partial inhibition of nitric oxide synthase primes the stimulated pathway of vWF-secretion in man. Atherosclerosis, 148(1), 43-47.
25. Golino, P., Buja, L. M., Ashton, J. H., Kulkarni, P., Taylor, A., & Willerson, J. T. (1988). Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries. Circulation, 78(3), 701-711.
26. Yao, S. K., Ober, J. C., McNatt, J., Benedict, C. R., Rosolowsky, M., Anderson, H. V., Cui, K., Maffrand, J. P., Campbell, W. B., & Buja, L. M. (1992). ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. Circulation Research, 70(1), 39-48.
27. Bush, L. R., Campbell, W. B., Buja, L. M., Tilton, G. D., & Willerson, J. T. (1984). Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. Circulation, 69(6), 1161-1170.
28. McGhie, A. I., McNatt, J., Ezov, N., Cui, K., Mower, L. K., Hagay, Y., Buja, L. M., Garfinkel, L. I., Gorecki, M., & Willerson, J. T. (1994). Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain. Circulation, 90(6), 2976-2981.
29. Bonetti, P. O., Barsness, G. W., Keelan, P. C., Schnell, T. I., Pumper, G. M., Kuvin, J. T., Schnall, R. P., Holmes, D. R., Higano, S. T., & Lerman, A. (2003). Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. Journal of the American College of Cardiology, 41(10), 1761-1768.
30. Kuvin, J. T., Patel, A. R., Sliney, K. A., Pandian, N. G., Sheffy, J., Schnall, R. P., Karas, R. H., & Udelson, J. E. (2003). Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. American Heart Journal, 146(1), 168-174.
31. Krantz, D. S., Santiago, H. T., Kop, W. J., Bairey Merz, C. N., Rozanski, A., & Gottdiener, J. S. (1999). Prognostic value of mental stress testing in coronary artery disease. American Journal of Cardiology, 84(11), 1292-1297.
32. Lavie, P., Shlitner, A., Sheffy, J., & Schnall, R. P. (2000). Peripheral arterial tonometry: a novel and sensitive non-invasive monitor of brief arousals during sleep. The Israel Medical Association Journal, 2(3), 246-247.
33. Bonetti, P. O., Pumper, G. M., Higano, S. T., Holmes, D. R., Jr., Kuvin, J. T., & Lerman, A. (2004). Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. Journal of the American College of Cardiology, 44(11), 2137-2141.
34. Rubinshtein, R., Kuvin, J. T., Soffler, M., Lennon, R. J., Lavi, S., Nelson, R. E., Pumper, G. M., Lerman, L. O., & Lerman, A. (2010). Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. European Heart Journal, 31(9), 1142-1148.
35. Woywodt, A., Bahlmann, F. H., De Groot, K., Haller, H., & Haubitz, M. (2002). Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer. Nephrology, Dialysis, Transplantation, 17(10), 1728-1730.
36. Mallat, Z., Benamer, H., Hugel, B., Benessiano, J., Steg, P. G., Freyssinet, J. M., & Tedgui, A. (2000). Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation, 101(8), 841-843.
37. Hamilos, H., Sarma, J., Ostojic, M., Cuisset, T., Sarno, G., Melikian, N., Ntalianis, A., Muller, O., Barbato, E., Belesin, B., Sagic, D., De Bruyne, B., Bartunek, J., & Wijns, W. (2008). Interference of drug-eluting stents with endothelium-dependant coronary vasomotion. Circulation: Cardiovascular Intervention, 1, 193-200.